Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Starpharma presenting at Citi investment conference in London

Abstract:
· CEO Dr Jackie Fairley presenting at the Citi Annual Australian and New Zealand Conference in London, 6th March 2012.

· Premier opportunity to further develop relationships with offshore investors.

· Starpharma selected as one of only four leading healthcare companies to present alongside 36 ASX listed companies.

Starpharma presenting at Citi investment conference in London

Melbourne, Australia | Posted on March 5th, 2012

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is one of four leading Australian healthcare companies invited to present at the 9th Citi Annual Australian and New Zealand Conference in London.



Commencing today, the conference is expected to be attended by more than 200 people including the leading institutional investors from London and Europe. Thirty six top ASX listed companies have been invited to present, most of which are in the ASX 100 index. The other Australian healthcare companies presenting are Cochlear Ltd, Sonic Healthcare Ltd and QRxPharma.



Starpharma Chief Executive Officer Dr Jackie Fairley said the Conference is an excellent opportunity to detail Starpharma's continuing progress and its strong links to the UK and Europe, including the recent investment by major UK based global fund M&G, which now holds 7% of Starpharma.



"We are delighted to present at the Conference alongside our peers and feel it's timely in consideration of our recent achievements and the expansion of our global investor footprint," said Dr Fairley.



In addition, Starpharma will be presenting at the ASX Emerging Growth Conference also in London on Thursday 8th March. In its fourth year, this London conference features a selection of emerging market leaders in the small to mid cap segment of the Australian public market.



As both conferences Dr Fairley will detail Starpharma's maturing development portfolio across sexual and women's health, drug delivery and agrochemical platforms. She will also discuss important upcoming commercial milestones.



Highlights of the presentation include:



VivaGel® Bacterial Vaginosis program: The European Medicines Agency (EMA) recently agreed to a Phase 3 clinical trial program for VivaGel® as a treatment for bacterial vaginosis (BV), in addition to the agreement reached with the US Food and Drug Administration (FDA) which includes Special Protocol Assessment (SPA) by FDA. A Phase 2 study of prevention of recurrence of BV is also underway.

Drug delivery program: Starpharma's dendrimer-docetaxel formulation was found recently to be significantly more effective than leading cancer drug docetaxel (Taxotere®) in breast cancer model.

Agrochemical program: The improved performance of market leading agrochemical candidates including glyphosate (active ingredient in Roundup®) when formulated with Starpharma's dendrimers.

Financials: Starpharma completed a A$35 million capital raising late last year firming up its strong cash position to $49 million at 31 December 2011. Net cash outflow from operations was $3.9 million.

####

For more information, please click here

Contacts:
BUCHAN CONSULTING
LEVEL 13 499 ST KILDA ROAD
MELBOURNE AUSTRALIA 3004
TEL +61 3 8866 1210
MOB +61 (0) 423 139 163
EMAIL www.buchanwe.com.au

Dr Jackie Fairley
Chief Executive Officer
TEL: +61-3-8532-2704

Copyright © Starpharma Holdings Limited

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

Bruker Announces Acquisition of High-Speed, 3D Super-Resolution Fluorescence Microscopy Company Vutara July 28th, 2014

Stanford team achieves 'holy grail' of battery design: A stable lithium anode - Engineers use carbon nanospheres to protect lithium from the reactive and expansive problems that have restricted its use as an anode July 27th, 2014

Iranian Scientists Produce Reusable Nanoadsorbent to Detect Sulfamide in Chicken July 27th, 2014

Investments/IPO's/Splits

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Harris & Harris Group Invests in UberSeq, Inc. July 16th, 2014

Harris & Harris Group Portfolio Company D-Wave Systems Closes a $28.4 Million Financing July 14th, 2014

Nanomedicine

New imaging agent provides better picture of the gut July 25th, 2014

Scientists Test Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer July 25th, 2014

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Announcements

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

Bruker Announces Acquisition of High-Speed, 3D Super-Resolution Fluorescence Microscopy Company Vutara July 28th, 2014

Stanford team achieves 'holy grail' of battery design: A stable lithium anode - Engineers use carbon nanospheres to protect lithium from the reactive and expansive problems that have restricted its use as an anode July 27th, 2014

Iranian Scientists Produce Reusable Nanoadsorbent to Detect Sulfamide in Chicken July 27th, 2014

Events/Classes

NNCO Announces an Interactive Webinar: Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy July 23rd, 2014

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

Iran to Hold 3rd Int'l Forum on Nanotechnology Economy July 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE